GENEMEDICS APP
GENEMEDICS NUTRITION
Tiger 17 benefits include accelerated wound healing, effective antimicrobial activity against resistant bacteria, promotion of tissue regeneration, and low cytotoxicity, making it an innovative solution for wound care and infection management.
One of the major health concerns worldwide is hard-to-treat wounds such as diabetes-induced skin ulcers and burn injuries. These wounds require long and sterile treatments as they increase the affected individualās risk of infection and permanent tissue damage. Recently, clinical trials have been conducted to find the ideal treatment for debilitating wounds. Researchers found that small peptides such as Tiger 17 peptide possess potent wound healing capacity via their actions on the production of wound healing agents such as transforming growth factor beta (TGF-β) and positive effects on the stages of healing.
Small peptides are short chains of amino acids, typically composed of 2 to 50 amino acids, linked by peptide bonds. They are smaller than proteins and play diverse roles in biological processes, including cell signaling, immune responses, and tissue repair. Due to their size and functional versatility, small peptides can act as hormones, neurotransmitters, or antimicrobial agents, influencing various physiological functions such as metabolism, growth, and defense mechanisms. Their stability, specificity, and bioactivity make them valuable in therapeutic applications, including drug development and regenerative medicine.
Tiger 17 exerts its potent wound-healing effects by increasing the production of transforming growth factor beta (TGF-β), a key regulator of cellular processes involved in tissue repair. This action enhances the stages of wound healing by promoting the migration and proliferation of fibroblasts, stimulating collagen synthesis, and modulating the inflammatory response. As a result, wounds heal more efficiently, with reduced scarring and faster recovery times, making Tiger 17 a promising agent for clinical and therapeutic applications in wound care.
Full-thickness dermal wound involves damage to the skin and subcutaneous tissue (fat layer). In one study, Tiger 17, a small peptide containing 11 amino acid residues, has been found to exert wound-healing effects in a mouse model of a full-thickness dermal wound. [1] Researchers found that Tiger 17 improves the wound healing process by:
A study highlights the benefits of Tiger 17 for full-thickness dermal wound healing by leveraging its antimicrobial properties and integrating it into nanofibrous polymer matrices created via electrospinning. [2] The research demonstrated that Tiger 17, synthesized through microwave-assisted solid-phase methodologies, effectively promotes localized and sustained antimicrobial action when immobilized in these matrices. The resulting bioactive dressings offer a combination of large surface area, porosity, and mechanical strength, facilitating enhanced wound healing while preventing infections. Advanced characterization techniques confirmed the structural, physical, and chemical properties of the biomolecule and its carrier, showcasing their potential as a robust solution for efficient dermal wound management.
Tiger 17 treats chronic wounds by modulating the wound-healing process through the upregulation of transforming growth factor beta (TGF-β). This cytokine plays a crucial role in enhancing fibroblast activity, promoting angiogenesis, and increasing collagen synthesis, all of which are essential for tissue repair and regeneration. Additionally, Tiger 17 helps to reduce prolonged inflammation, a common issue in chronic wounds, by balancing pro-inflammatory and anti-inflammatory signals. By addressing the underlying cellular and molecular dysfunctions that impede healing, Tiger 17 accelerates recovery, reduces the risk of infection, and improves the overall quality of tissue repair in chronic wounds.
To tackle chronic wound infections, this study developed PVA/CNC nanofibrous mats doped with peptides such as Tiger 17. [3] These mats showcased antimicrobial properties and Tiger 17ās unique capability to promote clot formation, essential for healing full-thickness dermal wounds. The matsā cytocompatibility and durable structure further highlight their potential for effective wound management.
Tiger 17 fights infection by boosting the immune systemās response and creating an environment hostile to pathogens. It enhances the production of antimicrobial peptides and cytokines, which help to neutralize harmful bacteria, viruses, and fungi. Additionally, Tiger 17 supports the activation of immune cells such as macrophages and neutrophils, which play key roles in identifying, engulfing, and destroying pathogens. This multi-faceted approach not only helps to clear infections but also reduces inflammation and promotes tissue repair, ensuring faster recovery and improved overall immune defense.
Tiger 17 may have beneficial effects on wound healing through its antibiotic properties. In one cell study, researchers found that exposure of various microorganisms such as Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli to Tiger 17 reduced bacterial presence. [4] In this study, microorganisms were exposed to Tiger 17 and commercial woven swabs. Results of the study showed that the presence of bacteria was significantly reduced by Tiger 17 compared to control.
In another study, researchers engineered a nanostructured mat that can simultaneously kill bacteria and promote an environment conducive to healing for prospective wound care. [5] Tiger 17 was incorporated onto the mats and demonstrated potent antibacterial activities against Staphylococcus aureus and Pseudomonas aeruginosa.
Tiger 17 stimulates collagen production and granulation tissue formation by upregulating the activity of transforming growth factor beta (TGF-β), a key signaling molecule involved in wound repair. TGF-β activates fibroblasts, promoting their proliferation and differentiation into myofibroblasts, which are essential for synthesizing collagen. This increased collagen production strengthens the extracellular matrix, providing structural support to the healing tissue. Additionally, Tiger 17 enhances angiogenesis, facilitating the formation of new blood vessels that supply oxygen and nutrients to the wound site. These processes collectively contribute to the development of granulation tissue, which serves as the foundation for further tissue regeneration and wound closure.
In one study, Tiger 17 has been found to improve the wound-healing process in mice by promoting the migration of keratinocytes and the formation of granulation tissue at the site of injury. [1] Since keratinocytes constitute 90% of the cells of the outermost skin layer (epidermis), migration into the wound can accelerate the healing process. Its additional effect on granulation tissue formation can benefit the overall stages of wound regeneration.
Another study found that Tiger 17 has the potential to treat non-healing wounds with deeper layers by stimulating the production of collagen, a protein necessary for the maintenance of the skin matrix. [6] This in turn speeds up the formation of granulation tissue (new connective tissue) and microscopic blood vessels at the site of injury during the process of regeneration. Granulation tissue normally forms from the base of a wound, allowing it to fill wounds with deeper layers of almost any size.
Unnatural amino acids (UAAs), also known as non-proteinogenic amino acids, are amino acids that are not among the 20 standard amino acids encoded by the universal genetic code. These UAAs can be synthesized artificially or occur naturally without being incorporated into proteins during translation. Peptides formed using UAAs are important for studying unique biochemical interactions.
Incorporating UAAs into proteins has become a valuable tool in biochemical research and synthetic biology. By expanding the genetic code to include UAAs, scientists can introduce novel functionalities into peptides and proteins, enabling the study of protein structure and function with greater precision. This approach has facilitated advancements in areas such as site-specific protein immobilization and the development of peptides and proteins with enhanced or novel properties.
The incorporation of UAAs into peptides and proteins is achieved through various methods, including the development of orthogonal tRNA-synthetase pairs that can recognize and incorporate UAAs at specific sites within a peptide or protein. This technique allows for the precise placement of UAAs in peptides, enabling detailed studies of protein interactions and functions. For example, researchers have used this method to investigate the role of specific residues in the inactivation of potassium channels, providing insights that were not possible with conventional mutagenesis of peptides. Peptides containing UAAs thus represent an essential tool for exploring complex biochemical systems.
Solid Phase Peptide Synthesis (SPPS) is a method for constructing peptides by sequentially adding protected amino acids to a growing chain anchored to an insoluble solid support, typically resin beads. This technique, introduced by Robert Bruce Merrifield in 1963, revolutionized peptide synthesis by simplifying purification processes and enabling automation, significantly enhancing efficiency and throughput.
The SPPS process involves repetitive cycles of deprotection and coupling. Initially, the C-terminal amino acid is attached to the resin. The N-terminal protecting group is then removed, allowing the next protected amino acid to couple to the free amine group. This cycleādeprotection followed by couplingāis repeated until the desired peptide sequence is assembled. After synthesis, the peptide is cleaved from the solid support, and all protecting groups are removed to yield the free peptide.
SPPS offers several advantages over traditional solution-phase synthesis, including increased speed, efficiency, and the ability to automate the process. By keeping the growing peptide chain attached to a solid support, excess reagents and by-products can be easily removed through washing and filtration, eliminating the need for laborious purification. Additionally, this method is particularly advantageous for producing complex peptides with high purity and yield, allowing researchers to create peptides for various applications, from drug development to biotechnology.
In summary, Solid Phase Peptide Synthesis is a powerful and efficient method for creating peptides with precision. The ability to automate peptide synthesis and easily purify peptides has transformed the field of biotechnology and led to the rapid development of therapeutic peptides and other applications requiring high-quality peptides. Researchers continue to innovate within this field, enhancing the efficiency of peptide synthesis and expanding the range of peptides that can be synthesized for diverse purposes.
Peptide synthesis is the chemical process of creating peptides, which are compounds composed of two or more amino acids linked by peptide bonds. This synthesis involves forming an amide bond between the carboxyl group of one amino acid and the amino group of another. To prevent unwanted side reactions during this process, protecting groups are often applied to the reactive functional groups of amino acids.
The most common method for peptide synthesis in laboratories is Solid Phase Peptide Synthesis (SPPS), developed by Robert Bruce Merrifield. In SPPS, the C-terminal amino acid is anchored to an insoluble resin, and the peptide chain is elongated by sequentially adding protected amino acids. After each addition, deprotection occurs to expose the next reactive site, allowing the process to repeat until the desired peptide sequence is achieved. Upon completion, the peptide is cleaved from the resin, and all protecting groups are removed to yield the final product.
Peptide synthesis is essential for producing peptides that are challenging to express in biological systems, incorporating non-natural amino acids, modifying peptide backbones, and creating D-proteins composed of D-amino acids. These synthetic peptides have significant applications in research, medicine, and industry, including the development of peptide-based drugs and the study of protein functions. Peptides are also used in the design of vaccines, diagnostic tools, and treatments for various diseases.
As of current research, the side effects associated with Tiger 17, a small peptide used in wound healing, are not extensively documented. However, potential concerns could include:
A small peptide is a short chain of amino acids, typically consisting of fewer than 50 amino acids. These peptides can serve various biological functions, including signaling, enzymatic activity, structural roles, or mediating protein-protein interactions. The presence of an amine group in the peptide structure plays a key role in these interactions, influencing the peptide’s reactivity and functionality. Peptides are also essential in studying protein-protein interactions, helping researchers understand cellular processes and their biological activities. Moreover, small peptides often influence biological mechanisms through direct protein-protein interactions, where the amine group contributes to their binding and activity, making them critical in both research and therapeutic applications, demonstrating a wide range of biological activities. Their biological activities make them a valuable tool for advancing our understanding of cell biology and disease mechanisms.
The smallest peptide hormone is thyrotropin-releasing hormone (TRH), which consists of just three amino acids, the basic building blocks of peptides. TRH plays a crucial role in regulating protein-protein interactions within the endocrine system. These protein-protein interactions are essential for its function, allowing TRH to interact with receptors and initiate signaling pathways. In some biomedical applications, poly vinyl alcohol (PVA) is used as a stabilizing agent for peptide hormones like TRH. The study of TRH also provides insights into protein-protein interactions in hormone signaling and regulation, and poly vinyl alcohol may aid in the delivery of such peptides for therapeutic purposes. Additionally, poly vinyl alcohol is utilized in drug delivery systems, further enhancing the understanding of peptide interactions and their applications in medicine, focusing on the role of building blocks like amino acids.
An example of a short peptide is glutathione, a tripeptide composed of glutamate, cysteine, and glycine, which plays a key role in cellular antioxidant defense. These amino acids are considered the building blocks of glutathione, contributing to its biological activity. Glutathione belongs to the broader category of bioactive peptides, including antimicrobial peptides, which are vital for immune defense by targeting microbial cells. Like glutathione, antimicrobial peptides also have specific functions, such as protecting against pathogens by disrupting microbial cells. The building blocks of antimicrobial peptides help determine their ability to interact with microbial membranes. Research on antimicrobial peptides highlights their importance in developing therapies for infections and oxidative stress-related conditions, especially those involving microbial cells.
Small peptides, often composed of eight amino acids or fewer, are absorbed primarily in the small intestine, where their chemical structures are broken down into dipeptides, tripeptides, or free amino acids before being transported into the bloodstream. Peptides consisting of eight amino acids play a vital role in biological processes, including accelerating clotting by influencing coagulation factors. Their chemical structures ensure efficient absorption and utilization by the body, further supporting functions like accelerating clotting and promoting tissue repair. This process highlights the significance of small peptides, particularly those with eight amino acids and their chemical structures, in maintaining essential metabolic functions, including accelerating clotting in response to injury.
Small peptide hormones are short chains of amino acids that regulate various physiological processes, such as insulin, which controls glucose metabolism, and oxytocin, which influences social bonding and childbirth. Cyclic peptides also play an important role in this category, acting as regulatory molecules that modulate different biological functions. The structure of cyclic peptides allows them to maintain stability and enhance their activity, making them valuable in therapeutic applications. Additionally, cyclic peptides are increasingly being explored for their potential in drug development due to their ability to target specific proteins with high precision. Research has shown that crosslinked fibers increased in certain tissue cultures can promote more effective peptide binding. Moreover, studies have demonstrated that crosslinked fibers increased the stability and potency of peptides, which could have important implications for drug design. As the understanding of crosslinked fibers increased, the potential for cyclic peptides to be used in targeted therapies continues to grow.
Small signaling peptides are peptides that act as messengers within or between cells, regulating processes such as growth, differentiation, and immune responses. Examples include cytokines and growth factors, which are commonly used as therapeutic agents. Ribosomal peptides, which are synthesized through the ribosome, play a significant role in these signaling processes. Additionally, ribosomal peptides are important for regulating cellular activities, and their role as therapeutic agents makes them crucial in various biological pathways. The versatility of these peptides highlights their potential as therapeutic agents in addressing diverse medical challenges.
The peptide BPC-157 is considered one of the best for injury repair, as it promotes tissue regeneration, accelerates wound healing, and reduces inflammation, particularly in cases involving bacterial infections. Peptide loading with BPC-157 offers unique healing properties that are highly beneficial in recovery from injuries and bacterial infections. Unlike many ribosomal peptides, BPC-157 provides targeted regenerative effects, making it an excellent choice for injury repair. Additionally, ribosomal peptides like BPC-157 are often utilized for their regenerative effects, and peptide loading enhances their potential in the treatment of bacterial infections and injury recovery.
Defensins are among the most effective antimicrobial peptides, as they exhibit broad-spectrum activity against bacteria, fungi, and viruses while supporting immune defenses. Ribosomal peptides, along with small molecules, which are naturally synthesized by ribosomes, also play a key role in antimicrobial activity. In addition to defensins, ribosomal peptides and small molecules contribute to the bodyās defense by targeting and neutralizing a variety of pathogens. The interplay between peptides and small molecules enhances the bodyās ability to combat infections effectively, with cytocompatibility data verified to support their safe use in therapeutic applications. Moreover, cytocompatibility data verified ensures that these peptides and molecules are well-tolerated in human tissues, minimizing adverse reactions. The continued development of these peptides benefits from cytocompatibility data verified, ensuring both efficacy and safety in clinical settings.
Tiger 17 accelerates wound healing by promoting tissue regeneration, reducing inflammation, and exhibiting strong antimicrobial activity to prevent infections, similar to the effects of ribosomal peptides in the body. Mass spectrometry is often used to analyze and characterize the structure and function of ribosomal peptides, providing insights into their role in enhancing the effectiveness of Tiger 17 in preventing bacterial growth. The unique properties of ribosomal peptides in Tiger 17, identified and studied using mass spectrometry, make it an effective solution for improving wound recovery and combatting infection. Additionally, mass spectrometry helps ensure the purity and stability of Tiger 17 during formulation and application.
Yes, Tiger 17 has shown effectiveness against antibiotic-resistant bacteria by disrupting microbial membranes, a mechanism less prone to resistance development. As a bioactive peptide, Tiger 17 exhibits unique properties that enhance its antimicrobial activity when incorporated into electrospun mats. The solid phase of electrospinning technology allows for efficient loading of bioactive peptides like Tiger 17, which are being increasingly recognized for their potential in combating resistant infections and promoting wound healing. This innovative approach demonstrates how Tiger 17’s properties can be optimized through electrospun mats for advanced medical applications, particularly when using solid phase synthesis to ensure high-quality peptide production.
Tiger 17 is distinguished by its broad-spectrum activity, low cytotoxicity to human cells, and enhanced stability in biological environments, partly due to its interaction with acetyl groups, making it highly effective for clinical applications. Similar to other venom peptides, Tiger 17ās ability to target microbial membranes, aided by the presence of acetyl groups, gives it a unique edge in wound care. Its structure, reminiscent of venom peptides, includes acetyl groups that enable it to deliver antimicrobial effects while promoting tissue regeneration.
Yes, Tiger 17 is suitable for treating chronic wounds due to its antimicrobial properties, ability to promote tissue regeneration, and reduction of biofilm formation, which is enhanced by the incorporation of D amino acids. The use of D amino acids in its structure provides greater stability and resistance to enzymatic degradation. In drug discovery, the incorporation of D amino acids is an important strategy for enhancing peptide stability and efficacy. Additionally, D amino acids contribute to the peptideās effectiveness in targeting and disrupting bacterial membranes, further supporting its role in wound healing and making it a valuable candidate in drug discovery.
Tiger 17 is incorporated into wound dressings, gels, and creams to deliver localized antimicrobial and regenerative effects directly to the wound site, showcasing its potential as a powerful peptide therapeutics. As part of the growing field of peptide therapeutics, Tiger 17 offers a novel approach to wound care by enhancing healing and preventing infection, which could contribute significantly to drug discovery. This peptide therapeutics provides a promising solution for both acute and chronic wound management, presenting new opportunities in drug discovery for infection control, tissue regeneration, and mats effectiveness in treating difficult-to-heal wounds. Its incorporation into various wound care products highlights mats effectiveness in preventing microbial contamination and promoting faster healing. As research advances, the impact of Tiger 17 on wound healing could lead to improved mats effectiveness for a wide range of medical and therapeutic applications.
Tiger 17 has a cationic and amphipathic structure, which allows it to interact with microbial membranes effectively while maintaining stability and selectivity. Thermal analyses proved that this structure is influenced by its sequence of L amino acids, enhancing its ability to target and disrupt bacterial membranes. Thermal analyses proved that the arrangement of L amino acids in Tiger 17 contributes to its stability and effectiveness in various medical applications. Thermal analyses proved that this unique structure ensures Tiger 17ās potency and durability in treating infections
Yes, Tiger 17 promotes tissue regeneration by stimulating cellular repair mechanisms and enhancing fibroblast and keratinocyte activity, similar to the effects seen in short peptides. The fibers swelling capacity of Tiger 17 contributes to its ability to support tissue regeneration and accelerate healing. Short peptides, like Tiger 17, play a crucial role in enhancing wound healing by supporting tissue regeneration. Additionally, the unique properties of short peptides and their fibers swelling capacity contribute to Tiger 17’s ability to accelerate healing and reduce infection risks. The fibers swelling capacity is an essential factor in enhancing the overall effectiveness of Tiger 17 in promoting faster and more efficient tissue repair.
Preliminary studies suggest that Tiger 17, a type of short peptide, is safe for use in pediatric and geriatric populations, but comprehensive clinical trials are needed to confirm its safety, with positive control groups included for comparison. Short peptides like Tiger 17 have shown promise in various medical applications due to their ability to promote tissue regeneration and reduce infection, often tested alongside a positive control to assess efficacy. Further research on short peptides, with appropriate positive control trials, is necessary to better understand their long-term effects and safety profiles in vulnerable populations.
Currently, no significant resistance mechanisms to Tiger 17 have been identified, likely due to its membrane-targeting mode of action. Unlike many short peptides that face resistance over time, Tiger 17 maintains its efficacy by disrupting microbial membranes. This characteristic makes it the most promising combination for treating resistant infections. The ability of Tiger 17 to sustain effectiveness without significant resistance sets it apart, making it the most promising combination for long-term antimicrobial therapies. This unique property positions Tiger 17 as the most promising combination for future clinical applications in infection control.
Yes, Tiger 17 can be combined with other treatments, such as growth factors or antibiotics, to enhance wound healing and infection control synergistically. Additionally, short peptides like Tiger 17 can complement other therapies, providing a more comprehensive approach to healing. Short peptides are also known for their ability to work in harmony with other compounds, optimizing the healing process. Time kill kinetics evaluations have shown that Tiger 17 exhibits rapid antimicrobial action, further supporting its role in combination therapy. These evaluations highlight the efficiency of Tiger 17 in reducing microbial load, making it an excellent adjunct in treatment strategies.
The shelf life of Tiger 17-containing products, which may include peptides derived from natural sources, depends on formulation and storage conditions but typically ranges from 12 to 24 months when properly stabilized. Peptides derived from synthetic methods are often used to enhance stability, ensuring the product remains effective throughout its shelf life in the pharmaceutical market. Additionally, the use of peptides derived from bioactive compounds contributes to the long-lasting efficacy of Tiger 17 products, positioning it as a competitive option in the growing pharmaceutical market. As the demand for innovative treatments rises, products like Tiger 17 continue to make an impact in the pharmaceutical market.
Tiger 17 is stabilized using methods such as lyophilization, encapsulation in nanoparticles, or the addition of stabilizing agents to prevent degradation, ensuring the integrity of biological compounds and maintaining a uniform structure. These stabilization techniques help preserve the activity of biological compounds in various formulations, maintaining their uniform structure and effectiveness over time. The use of these methods is critical for enhancing the shelf life and performance of biological compounds like Tiger 17 in medical applications, while ensuring their uniform structure remains intact.
Yes, Tiger 17 has potential applications in dental care for treating periodontal infections by targeting the cell membrane of bacteria, and in surgical settings for preventing infections and promoting post-operative healing by disrupting the cell membrane of pathogens. Its ability to interact with the cell membrane makes it an effective antimicrobial agent in both oral and surgical applications.
Tiger 17, a therapeutic peptide, disrupts microbial membranes by binding to and destabilizing lipid bilayers, causing leakage of cellular contents and microbial death. As a therapeutic peptide, Tiger 17 offers a powerful mechanism of action that targets a wide range of pathogens. This therapeutic peptide’s ability to destabilize microbial membranes makes it an effective solution for infection control and wound healing.
Yes, ongoing clinical trials are evaluating Tiger 17 for its efficacy in wound care, infection control, and tissue regeneration, including the potential use of vinyl alcohol-based formulations. Fourier transform infrared spectroscopy is being employed in these trials to analyze the chemical interactions between vinyl alcohol and Tiger 17. These trials explore the integration of vinyl alcohol to enhance the stability and delivery of Tiger 17. Additionally, researchers are investigating how vinyl alcohol compounds can optimize the effectiveness of Tiger 17 in clinical settings using Fourier transform infrared spectroscopy to monitor structural changes.
Tiger 17 is most effective against Gram-positive and Gram-negative bacteria, including antibiotic-resistant strains like MRSA and Pseudomonas aeruginosa, by targeting extracellular and intracellular targets. Its ability to disrupt microbial membranes and engage intracellular targets, potentially through hydrogen bonds with key microbial components, makes it a powerful tool in combating infections. Additionally, Tiger 17ās action on intracellular targets, which involves forming hydrogen bonds with specific cellular structures, contributes to its effectiveness against a variety of resistant pathogens. Finally, the formation of hydrogen bonds enhances its interaction with microbial membranes, boosting its antimicrobial potency.
Tiger 17 offers comparable or superior effectiveness to synthetic agents, especially against resistant pathogens, and can be a more potent alternative to linear peptides in certain applications, thanks to its α helix structure. However, its cost may be higher due to production complexity, particularly when compared to simpler linear peptides, as indicated in multiple data reports. Despite this, Tiger 17 remains a promising option due to its unique α helix structure and effectiveness in combating infections, as highlighted in several data reports. The α helix structure of Tiger 17 contributes to its stability and efficiency in targeting microbial membranes.
Yes, Tiger 17 is suitable for infected or necrotic wounds as it reduces microbial load, prevents biofilm formation, and promotes tissue regeneration. The peptide concentration in Tiger 17 enhances its antimicrobial and regenerative effects, helping to prevent excessive drying that could hinder healing. Optimal peptide concentration ensures that the therapeutic properties of Tiger 17 are maximized for effective wound care, while also avoiding excessive drying that can impair tissue regeneration. Adjusting the peptide concentration can further tailor its activity to specific clinical needs, minimizing the risk of excessive drying in sensitive wound areas.
Tiger 17 may improve skin texture, reduce scarring, and accelerate healing, making it a candidate for cosmetic applications in skin repair and rejuvenation. Its structural diversity allows it to effectively interact with a wide range of pathogens while promoting tissue regeneration. The structural diversity of Tiger 17 also contributes to its enhanced stability and efficacy in medical formulations. This versatility in structure ensures its potential for broader applications, including skin rejuvenation and wound care.
Yes, Tiger 17 is biodegradable, and its environmental impact is minimal compared to synthetic antimicrobial agents. Additionally, when considering peptide modified mats safety, Tiger 17 demonstrates a favorable profile for use in medical products. This makes it a promising strategy for wound care, as it ensures both effectiveness and safety. Its low cytotoxicity ensures that peptide modified mats safety remains a priority in clinical settings, providing a promising strategy for patient care. As a result, it offers a safe and effective solution, contributing to overall peptide modified mats safety in wound care and other applications, reinforcing it as a promising strategy in medical treatments.
Tang J, Liu H, Gao C, et al. A small peptide with potential ability to promote wound healing. PLoS ONE. 2014;9(3):e92082.
A small peptide with potential ability to promote wound healing
Tiger 17 stimulates collagen production and granulation tissue formation by upregulating the activity of transforming growth factor beta (TGF-β), a key signaling molecule involved in wound repair. TGF-β activates fibroblasts, promoting their proliferation and differentiation into myofibroblasts, which are essential for synthesizing collagen. This increased collagen production strengthens the extracellular matrix, providing structural support to the healing tissue. Additionally, Tiger 17 enhances angiogenesis, facilitating the formation of new blood vessels that supply oxygen and nutrients to the wound site. These processes collectively contribute to the development of granulation tissue, which serves as the foundation for further tissue regeneration and wound closure.
You can read the full article at https://pmc.ncbi.nlm.nih.gov/articles/PMC3960170/.
Tiger 17 Peptide Loaded Polycaprolactone/Cellulose Acetate Electrospun Nanofibrous Mats for Applications in Cutaneous Wound Dressings
Improperly treated skin wounds can become chronic and prone to severe infections, potentially leading to death. Tissue engineering combines engineering, chemistry, and biology to repair and improve tissue function, while the textile field uses polymeric fibers to create bioactive dressings with high porosity and mechanical strength for effective healing and antimicrobial action. This research synthesized Tiger 17 via microwave-assisted methods, characterized its structure and antimicrobial capacity, and developed electrospun nanofibrous polymer matrices to immobilize the biomolecule for controlled, localized antimicrobial delivery, using advanced physical and chemical characterization techniques.
You can read the abstract of this article at https://www.researchgate.net/publication/366877739_Tiger_17_Peptide_Loaded_PolycaprolactoneCellulose_Acetate_Electrospun_Nanofibrous_Mats_for_Applications_in_Cutaneous_Wound_Dressings.
Available from https://www.sciencedirect.com/science/article/pii/S2772950822001078.
Antibacterial and hemostatic capacities of cellulose nanocrystalline-reinforced poly(vinyl alcohol) electrospun mats doped with Tiger 17 and pexiganan peptides for prospective wound healing applications
Researchers developed polyvinyl alcohol (PVA) nanofibrous mats reinforced with cellulose nanocrystals (CNC) and doped with antimicrobial peptides for chronic wound care. The mats were crosslinked with glutaraldehyde vapor to enhance their stability, with added peptides like pexiganan and Tiger 17 providing antimicrobial properties and promoting clotting. While CNC incorporation reduced mechanical strength, it improved surface energy and long-term structural stability. The mats demonstrated effectiveness against Staphylococcus aureus and Pseudomonas aeruginosa, with C90/10 PVA/CNC mats being the most promising option for chronic wound treatment due to their antimicrobial activity and cytocompatibility.
You can read the full article at https://www.sciencedirect.com/science/article/pii/S2772950822001078.
Available from http://repositorium.sdum.uminho.pt/handle/1822/57028.
Tiger 17 functionalized onto PVA/CA films accelerates clotting time and reduces microbial action
Acute wound healing is a predictable process, while chronic wounds result from tissue degradation, characterized by issues like defective cell matrix, high bacteria counts, and prolonged inflammation. Chronic wound treatment requires expensive, individualized care such as mechanical debridement, topical antibiotics, and moisture-managing dressings. Antimicrobial dressings have been suggested, but the rise of antibiotic-resistant infections has shifted focus to antimicrobial peptides (AMPs), which are effective against pathogens and reduce resistance development. In this study, poly(vinyl alcohol) (PVA) and cellulose-acetate (CA) films were functionalized with the antimicrobial peptide Tiger17, which has potential for wound healing and immunoregulatory properties.
You can read the abstract of this article at https://repositorium.sdum.uminho.pt/handle/1822/57028.
Teixeira, M. A., Antunes, J. C., Seabra, C. L., Tohidi, S. D., Reis, S., Amorim, M., & Felgueiras, H. P. (2022). Tiger 17 and pexiganan as antimicrobial and hemostatic boosters of cellulose acetate-containing poly(vinyl alcohol) electrospun mats for potential wound care purposes. International journal of biological macromolecules, 209(Pt A), 1526ā1541. https://doi.org/10.1016/j.ijbiomac.2022.04.130.
Tiger 17 and pexiganan as antimicrobial and hemostatic boosters of cellulose acetate-containing poly(vinyl alcohol) electrospun mats for potential wound care purposes
This research develops a nanostructured mat for wound care that kills bacteria and promotes healing. By electrospinning and crosslinking polyvinyl alcohol (PVA) and cellulose acetate (CA) at varying ratios, the mats were optimized for antimicrobial and hemostatic properties. The mats incorporated antimicrobial peptide cys-pexiganan and immunoregulatory peptide Tiger 17, which were effective against bacterial infections and enhanced clotting. The 90/10 PVA/CA mats showed the best balance of properties, including hydrophilicity, swelling capacity, and peptide loading, proving to be cytocompatible and promising for wound healing.
You can read the full article at https://www.sciencedirect.com/science/article/pii/S0141813022008376?via%3Dihub.
Mangoni ML, McDermott AM, Zasloff M. Antimicrobial peptides and wound healing: biological and therapeutic considerations. ExpDermatol. 2016;25(3):167ā173. doi:10.1111/exd.12929.
Antimicrobial peptides and wound healing: biological and therapeutic considerations
Tissue wound repair is essential for restoring tissue integrity, but infection often impedes healing. Antimicrobial peptides (AMPs) are key defense molecules that help control microbial growth and modulate the immune response. This review highlights the role of AMPs in wound healing and their potential as therapeutic agents for treating non-life-threatening skin and epithelial injuries.
You can read the full article at https://pmc.ncbi.nlm.nih.gov/articles/PMC4789108/.
At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions Iāve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old
Movie Director (āThe Notebookā, āJohn Qā, āAlpha Dogā), Actor and Writer
I am now in my mid-sixties and feel better than I did in my 20ās. Many people have commented that I actually look 20 years younger since I started the program at Genemedics.
Calling Dr. George has proven to be one of the best decisions I have made in my life. Doctors and society convince us that developing various health issues and negative sy...
Pamela Hill ,66 yrs old
Call 800-277-4041 for a Free Consultation
GenemedicsĀ® Health Institute is a global premier institute dedicated to revolutionizing health and medicine through healthy lifestyle education, guidance and accountability in harmony with functional medicine. Our physician-supervised health programs are personally customized to help you reach your health and fitness goals while looking and feeling better than ever.
© Copyright Genemedics Health Institute. All Rights Reserved. Privacy Policy.
STEPS AWAY FROM A YOUNGER. HEALTHIER YOU!
Call 800-277-4041 for a Free Consultation
What to expect during your consultation: